Pulp treatment for extensive decay in primary teeth

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  Smaïl Faugeron, Violaine ^a   Courson, Frédéric ^a   Durieux, Pierre ^b   Muller Bolla, Michele ^c   Glenny, Anne Marie ^d   Fron Chabouis, Helene ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM HYDROXIDE; DENTAL MATERIAL; FERRIC SULFATE; FORMOCRESOL; GLUTARALDEHYDE; IODOFORM; MINERAL TRIOXIDE AGGREGATE; UNCLASSIFIED DRUG; ZINC OXIDE; ALUMINUM DERIVATIVE; CALCIUM DERIVATIVE; FERRIC ION; OXIDE; SILICATE; TOOTH CEMENT; ZINC OXIDE EUGENOL;

COMPARATIVE EFFECTIVENESS; DECIDUOUS TOOTH; DENTAL CARIES; DENTAL PULP CAPPING; DENTAL RESTORATION; DENTIN; FOLLOW UP; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; PATHOLOGY; PRIORITY JOURNAL; PULPECTOMY; PULPOTOMY; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TOOTH CEMENTUM; TREATMENT DURATION; TREATMENT OUTCOME; CHILD; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG COMBINATION; ELECTROSTIMULATION THERAPY; ENDODONTICS; META ANALYSIS; METHODOLOGY; MOLAR TOOTH; PRESCHOOL CHILD;

ALUMINUM COMPOUNDS; CALCIUM COMPOUNDS; CALCIUM HYDROXIDE; CHILD; CHILD, PRESCHOOL; CONTROLLED CLINICAL TRIALS AS TOPIC; DENTAL CARIES; DENTAL CEMENTS; DENTAL MATERIALS; DRUG COMBINATIONS; ELECTRIC STIMULATION THERAPY; FERRIC COMPOUNDS; FORMOCRESOLS; HUMANS; MOLAR; OXIDES; PULPECTOMY; PULPOTOMY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SILICATES; TOOTH, DECIDUOUS; ZINC OXIDE-EUGENOL CEMENT;

EID: 84907168854     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003220.pub2     Document Type: Review

References (116)

1. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal 2007; Vol. 40, issue 4:261-7.
2. Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatric Dentistry 2004; Vol. 26, issue 4:302-9.
3. Alaçam A. Long term effects of primary teeth pulpotomies with formocresol, glutaraldehyde-calcium and glutaraldehyde-zinc oxide eugenol on succudaneous teeth. Journal of Pedodontics 1989;13:307-13.
4. Alaçam A. Pulpal tissue changes following pulpotomies with formocresol, glutaraldehyde-calcium hydroxide, glutaraldehyde-zinc oxide eugenol pastes in primary teeth. Journal of Pedodontics 1989;13:123-32.
5. Alaçam A, Odabas ME, Tuzuner T, Sillelioglu H, Baygin O. Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 2009;108(5):e127-33.
6. Aminabadi NA, Farahani RM, Oskouei SG. Formocresol versus calcium hydroxide direct pulp capping of human primary molars: two year follow-up. Journal of Clinical Pediatric Dentistry 2010;34(4):317-21. [PUBMED: 20831133]
7. Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. International Endodontic Journal 2010;43(5):413-8. [PUBMED: 20518934]
8. Bahrololoomi Z, Moeintaghavi A, Emtiazi M, Hosseini G. Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: a randomized clinical trial. Indian Journal of Dental Research 2008; Vol. 19, issue 3:219-23.
9. Casas MJ, Kenny DJ, Johnston DH, Judd PL. Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry 2004;26(1):44-8.
10. Casas MJ, Layug MA, Kenny DJ, Johnston DH, Judd PL. Two-year outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatric Dentistry 2003;25(2):97-102. [PUBMED: 12723832]
11. Coser RM, Gondim JO, Aparecida Giro EM. Evaluation of 2 endodontic techniques used to treat human primary molars with furcation radiolucency area: a 48-month radiographic study. Quintessence International 2008;39(7):549-57.
12. Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures on children. International Journal of Paediatric Dentistry 2002;12:177-82. [MEDLINE: 22024492]
13. Demir T, Cehreli ZC. Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2-year results. American Journal of Dentistry 2007;20(3):182-8.
14. Doyle TL, Casas MJ, Kenny DJ, Judd PL. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy. Pediatric Dentistry 2010;32(1):41-7. [PUBMED: 20298652]
15. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatric Dentistry 2001;23(1):15-8. [MEDLINE: 21133329]
16. Erdem AP, Guven Y, Balli B, Ilhan B, Sepet E, Ulukapi I, et al.Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study. Pediatric Dentistry 2011;33(2):165-70. [PUBMED: 21703067]
17. Farsi N, Alamoudi N, Balto K, Mushayt A. Success of mineral trioxide aggregate in pulpotomized primary molars. Journal of Clinical Pediatric Dentistry 2005;29(4):307-11.
18. Fei AL, Udin RD, Johnson R. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth. Pediatric Dentistry 1991;13(6):327-32. [MEDLINE: 93181319]
19. Fishman SA, Udin RD, Good DL, Rodef F. Success of electrofulguration pulpotomies covered by zinc oxide and eugenol or calcium hydroxide: a clinical study. Pediatric Dentistry 1996;18(5):385-90. [MEDLINE: 97052902]
20. Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: long-term follow up. Pediatric Dentistry 1997;19(5):327-30.
21. Garrocho-Rangel A, Flores H, Silva-Herzog D, Hernandez-Sierra F, Mandeville P, Pozos-Guillen AJ. Efficacy of EMD versus calcium hydroxide in direct pulp capping of primary molars: a randomized controlled clinical trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 2009;107(5):733-8.
22. Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatric Dentistry 2005; Vol. 27, issue 2:129-36.
23. Huth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, Crispin A, Hickel R, et al.Effectiveness of 4 pulpotomy techniques - randomized controlled trial. Journal of Dental Research 2005;84(12):1144-8.
24. Ibricevic H, Al-Jame Q. Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up. Journal of Clinical Pediatric Dentistry 2000;24(4):269-72. [MEDLINE: 21210539]
25. Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow-up study. European Journal of Paediatric Dentistry 2003;4(1):28-32. [PUBMED: 12870985]
26. Malekafzali B, Shekarchi F, Asgary S. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial. European Journal of Paediatric Dentistry 2011;12(3):189-93. [PUBMED: 22077689]
27. Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. European Journal of Paediatric Dentistry 2005; Vol. 6, issue 3:133-8.
28. Moretti AB, Sakai VT, Oliveira TM, Fornetti AP, Santos CF, Machado MA, et al.The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal 2008; Vol. 41, issue 7:547-55.
29. Mortazavi M, Mesbahi M. Comparison of zinc oxide and eugenol, and Vitapex for root canal treatment of necrotic primary teeth. International Journal of Paediatric Dentistry 2004; Vol. 14, issue 6:417-24.
30. Nadkarni U, Damle SG. Comparative evaluation of calcium hydroxide and zinc oxide eugenol as root canal filling materials for primary molars: a clinical and radiographic study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 2000;18(1):1-10. [MEDLINE: 21222096]
31. Naik S, Hegde AH. Mineral trioxide aggregate as a pulpotomy agent in primary molars: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 2005;23(1):13-6. [PUBMED: 15858300]
32. Nakornchai S, Banditsing P, Visetratana N. Clinical evaluation of 3Mix and Vitapex as treatment options for pulpally involved primary molars. International Journal of Paediatric Dentistry 2010;20(3):214-21. [PUBMED: 20409203]
33. Noorollahian H. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. British Dental Journal 2008; Vol. 204, issue 11:E20.
34. Ozalp N, Saroglu I, Sonmez H. Evaluation of various root canal filling materials in primary molar pulpectomies: an in vivo study. American Journal of Dentistry 2005; Vol. 18, issue 6:347-50.
35. Pinky C, Shashibhushan KK, Subbareddy VV. Endodontic treatment of necrosed primary teeth using two different combinations of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 2011;29(2):121-7. [PUBMED: 21911950]
36. Prabhakar AR, Sridevi E, Raju OS, Satish V. Endodontic treatment of primary teeth using combination of antibacterial drugs: an in vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 2008;26(5):5-10.
37. Ramar K, Mungara J. Clinical and radiographic evaluation of pulpectomies using three root canal filling materials: an in-vivo study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 2010;28(1):25-9. [PUBMED: 20215668]
38. Sabbarini J, Mohamed A, Wahba N, El-Meligy O, Dean J. Comparison of enamel matrix derivative versus formocresol as pulpotomy agents in the primary dentition. Journal of Endodontics 2008; Vol. 34, issue 3:284-7.
39. Sakai VT, Moretti ABS, Oliveira TM, Fornetti APC, Santos CF, Machado M, et al.Summary of pulpotomy of human primary molars with MTA and Portland cement: a randomised controlled trial. British Dental Journal 2009;207(3):128-9. [: 0007-0610]
40. Saltzman B, Sigal M, Clokie C, Rukavina J, Titley K, Kulkarni GV. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry 2005; Vol. 15, issue 6:437-47.
41. Shumayrikh NM, Adenubi JO. Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endodontics & Dental Traumatology 1999;15(6):259-64. [MEDLINE: 20285582]
42. Sonmez D, Sari S, Cetinbas T. A comparison of four pulpotomy techniques in primary molars: a long-term follow-up. Journal of Endodontics 2008;34(8):950-5.
43. Subramaniam P, Konde S, Mathew S, Sugnani S. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study. Journal of Clinical Pediatric Dentistry 2009; Vol. 33, issue 4:311-4.
44. Subramaniam P, Gilhotra K. Endoflas, zinc oxide eugenol and Metapex as root canal filling materials in primary molars - a comparative clinical study. Journal of Clinical Pediatric Ddentistry 2011;35(4):365-9. [PUBMED: 22046693]
45. Trairatvorakul C, Chunlasikaiwan S. Success of pulpectomy with zinc oxide-eugenol vs calcium hydroxide/iodoform paste in primary molars: a clinical study. Pediatric Dentistry 2008; Vol. 30, issue 4:303-8.
46. Tuna D, Olmez A. Clinical long-term evaluation of MTA as a direct pulp capping material in primary teeth. International Endodontic Journal 2008; Vol. 41, issue 4:273-8.
47. Vargas KG, Packham B, Lowman D. Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry 2006; Vol. 28, issue 6:511-7.
48. Waterhouse PJ, Nunn JH, Whitworth JM. An investigation of the relative efficacy of Buckley's formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal 2000;188(1):32-6. [MEDLINE: 20162444]
49. Waterhouse PJ, Nunn JH, Whitworth JM. Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry 2002;12(2):116-23. [PUBMED: 11966889]
50. Zealand CM, Briskie DM, Botero TM, Boynton JR, Hu JC. Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars. Pediatric Dentistry 2010;32(5):393-9. [PUBMED: 21070705]
51. Zurn D, Seale NS. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial. Pediatric Dentistry 2008; Vol. 30, issue 1:34-41.
52. Abdel-Aziz A, Abdella A. Clinical and histological evaluation of three antiseptics used in abscessed primary molars. Pediatric Dentistry 1999;21(5):115.
53. Aktoren O, Gencay K. A two year clinical-radiographic follow-up of the pulpotomies in primary molars. Journal of Dental Research 2000;79:543 (Abs No 3193).
54. Ansari G, Vahid Golpaygani M, Chitsazan I, Fekrazad R. Clinical and radiographic evaluation of diode laser pulpotomy on human primary teeth: a preliminary study. Lasers in Medical Science Conference: World Federation for Laser Dentistry (WFLD). Hong Kong, 2009; Vol. 24(3):470-1.
55. Ayrton Ode T, Benfatti SV, Andrioni JN. Clinical and morphological study of a therapeutic agent with formaldehyde base for the preservation of the deciduous teeth [Estudio clínico y morfológico de un medicamento con base de formaldehida para la conservación de los dientes temporales]. El Cooperador Dental; Cooperativismo, Información y Ciencia Odontológica 1969;35(1):16-21. [PUBMED: 5255812]
56. Badzian-Kobos K, Walczak A. Clinical evaluation of the results of treatment of live dental pulp with Ledermix and Calxyl in some pulp diseases in children [Kliniczna ocena wynikow leczenia przyzyciowego niektorych stanow chorobowych miazgi zebow dzieciecych preparatami "Ledermix" i "Calxyl"]. Czasopismo Stomatologiczne 1967;20(11):1139-43. [PUBMED: 4965461]
57. Beaver HA, Kopel HM, Sabes WR. The effect of zinc oxide - eugenol cement on a formocresolized pulp. Journal of Dentistry for Children 1966;33:381-96. [MEDLINE: 1967042791]
58. Berrebi J, Heysselaer D, Nyssen-Behets C, Rocca JP, Mahler P, Limme M, et al.Clinical treatment of exposed pulp by direct capping/pulpotomy on primary and permanent immature teeth. Lasers in Medical Science Conference: World Federation for Laser Dentistry (WFLD). Hong Kong, 2009; Vol. 24(3):472.
59. Boggs DC. Simple technique for treating non-vital deciduous teeth - a study. Northwest Dentistry 1969;48(2):102-4. [PUBMED: 5253110]
60. Brannstrom M, Nyborg H, Stromberg T. Experiments with pulp capping. Oral Surgery, Oral Medicine, and Oral Pathology 1979;48(4):347-52. [PUBMED: 291861]
61. Casas M, Kenny D, Johnston D, Judd P, Layug M. Three-year prospective outcome study of ferric sulphate pulpotomies and root canal treatment in vital primary molars. International Journal of Paediatric Dentistry 2003;13 Suppl 1:9.
62. Chien MM, Setzer S, Cleaton-Jones P. How does zinc oxide-eugenol compare to ferric sulphate as a pulpotomy material?. Journal of the South African Dental Association 2001;56(3):130-5. [: CN-00567178]
63. Cuisia ZE, Musselman R, Schneider P, Dummett C. A study of mineral trioxide aggregate pulpotomies in primary molars. Pediatric Dentistry 2001;23(2):168.
64. Damle SG, Nadkarni U. A comparative study of two root canal resorbable filling materials in primary molars. International Journal of Paediatric Dentistry 1999;9 Suppl 1:86 (Abs No 35.03).
65. Droter JA. Pulp therapy in primary teeth. Journal of Dentistry for Children 1967;34(6):507-10. [PUBMED: 4864184]
66. Einwag J. Endodontics in primary dentition [Endodontie im milchgebiss]. Zahnarztliche Mitteilungen 1991;81(9):878-84. [PUBMED: 1906661]
67. Elomaa M, Rantanen L, Nystrom M. Use of chemotherapeutic-corticoid combination in vital pulpotomy. Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran Toimituksia 1974;70(1):1-6. [PUBMED: 4821944]
68. Fuks AB, Papagiannoulis L, Geki S, Koulatzidou M, Polychronopoulou A. One-year comparative study in pulpotomized primary teeth using ferric sulfate and diluted formocresol. European Journal of Paediatric Dentistry 2000;1(3):128 (Abs No 98).
69. Grivu O, Mecher E, Stoica E. Principles and present status of the therapy of pulp diseases in children [Principiile si stadiul actual al terapiei pulpopatiilor la copii]. Stomatologia 1966;13(3):233-44. [PUBMED: 5224151]
70. Hannah DR. Glutaraldehyde and calcium hydroxide. A pulp dressing material. British Dental Journal 1972;132(6):227-31. [PUBMED: 4504039]
71. Hansen HP, Ravn JJ, Ulrich D. Vital pulpotomy in primary molars. A clinical and histologic investigation of the effect of zinc oxide-eugenol cement and Ledermix. Scandinavian Journal of Dental Research 1971;79:13-23.
72. Hartsook JT. Pulpal therapy in primary and young permanent teeth. Dental Clinics of North America 1966:377-89. [PUBMED: 4222772]
73. Ibricevic H, Al-Jame G. Ferric sulfate as pulpotomy agent in primary teeth: clinical study. Journal of Dental Research 2001;80(4):1216 (Abs No 123).
74. Kalaskar RR, Damle SG. Comparative evaluation of lyophilized freeze dried platelet derived preparation with calcium hydroxide as pulpotomy agents in primary molars. Journal of the Indian Society of Pedodontics and Preventive Dentistry 2004;22(1):24-9.
75. Keszler A, Dominguez FV. Current status of pulp treatment with formocresol [Estado actual del tratamiento pulpar con formocresol]. Revista Española de Endodoncia 1987;5(2):63-70. [PUBMED: 3483227]
76. Kouri EM, Matthews JL, Taylor PP. Epinephrine in pulpotomy. ASDC Journal of Dentistry for Children 1969;36(2):123-8. [PUBMED: 4888301]
77. Liu JF. Nd:YAG laser pulpotomy of human primary teeth. Lasers in Dentistry, Proceedings: Revolution of Dental Treatment in the New Millennium 2003:251-6.
78. Liu JF. Effects of Nd:YAG laser pulpotomy on human primary molars. Journal of Endodontics 2006; Vol. 32, issue 5:404-7.
79. Mani SA, Chawla HS, Goel A. Zinc oxide-eugenol or calcium hydroxide as root canal filling material in primary teeth. International Journal of Paediatric Dentistry 1999;9 Suppl 1:113.
80. Massler M. Preventive endodontics: vital pulp therapy. Journal of the Dental Association of South Africa 1968;23(1):208-15. [PUBMED: 5243415]
81. Mejare I. Pulpotomy of primary molars with coronal or total pulpitis using formocresol technique. Scandinavian Journal of Dental Research 1979;87(3):208-16.
82. Odabas ME, Bodur H, Baris E, Demir C. Clinical, radiographic, and histopathologic evaluation of Nd:YAG laser pulpotomy on human primary teeth. Journal of Endodontics 2007; Vol. 33, issue 4:415-21.
83. Percinoto C, de Castro AM, Pinto LM. Clinical and radiographic evaluation of pulpotomies employing calcium hydroxide and trioxide mineral aggregate. General Dentistry 2006;54(4):258-61. [PUBMED: 16903198]
84. Punwani I, Fadavi S. The efficacy of pulpfixÆ glutaraldehyde pulpotomy agent for the treatment of vital primary teeth with carious pulp exposure. Journal of Dental Research 1993;72:212 (IADR Abs No 869).
85. Ram D, Moskovitz M, Fuks AB. Ferric sulfate versus formocresol in pulpotomized primary molars: clinical and radiographic results. Journal of Dental Research 2001;80:1311 (Abs No 20).
86. Ravn JJ, Svarrer M. A clinicoradiographic follow-up study of coronal vital pulpotomy in 200 primary molars treated with zinc-oxide-eugenol paste [En klinisk-radiologisk efterundersogelse af koronal vitalamputation i 200 primaere molarer, behandlet med zinkilte-euge-nol som amputationspasta]. Tandlaegebladet 1968;72(8):718-26. [PUBMED: 5247171]
87. Reddy VVS, Fernandes. Clinical and radiological evaluation of zinc oxide-eugenol and Maisto's paste as obturating materials in infected primary teeth - nine months study. Journal of the Indian Society of Pedodontics and Preventive Dentistry 1996;14(2):39-44.
88. Redig DF. A comparison and evaluation of two formocresol pulpotomy technics utilizing "Buckley's" formocresol. Journal of Dentistry for Children 1968;35:22-30. [MEDLINE: 68099489]
89. Riccioli GA. Conservative therapy of the deciduous teeth [A proposito di terapie conservatrice dei decidui]. Mondo Odontostomatologico 1971;14(1):65-7. [PUBMED: 5317205]
90. Ripa LW. Pulp therapy in live deciduous teeth [Terapeutica pulpar para dientes temporales vivos]. Fauchard 1971;2(6):114-7. [PUBMED: 5288029]
91. Ritwik P, Cuisia ZV, Dabir P, Musselman RJ. MTA pulpotomies in the primary molars of children: results after 3 years. International Journal of Paediatric Dentistry 2003;13 Suppl 1:11.
92. Rivera N, Reyes E, Mazzaoui S, Moron A. Pulpal therapy for primary teeth: formocresol vs electrosurgery: a clinical study. Journal of Dentistry for Children 2003;70(1):71-3. [PUBMED: 12762614]
93. Rocha M, Baroni R, Santos L, Girardi K. Calcium hydroxide and MTA pulpotomies in primary teeth: one year results. International Journal of Paediatric Dentistry 1999;9 Suppl 1:102.
94. Rule DC, Winter GB. Root growth and apical repair subsequent to pulpal necrosis in children. British dental journal 1966;120(12):586-90. [PUBMED: 5221182]
95. Sargenti A. Rational root therapy of deciduous teeth with N2 [Die rationelle Wurzelbehandlung der Milchzahne mit N2]. Zahnarztliche Praxis 1975;26(9):198-200. [PUBMED: 1057341]
96. Sayegh FS, Reed AJ. Correlated clinical and histological evaluation of Hydrex in pulp therapy. Journal of Dentistry for Children 1967;34(6):471-7. [PUBMED: 4864180]
97. Sogbe de Agell R. Clinical and radiographic evaluation of deciduous molars with necrotic pulp treated with two concentrations of formocresol. Acta Odontológica Venezolana 1989;27(1):3-9. [MEDLINE: 90328016]
98. Szabo H, Beczner S, Matavovszky M. Dental pulp treatment with "N2" material in deciduous molars [Tejmolarisok pulpakezelese "N2" anayaggal]. Fogorvosi Szemle 1968;61(12):268-70. [PUBMED: 5251838]
99. Tsai TP, Su HL, Tseng LH. Glutaraldehyde preparations and pulpotomy in primary molars. Oral Surgery, Oral Medicine, and Oral Pathology 1993;76(3):346-50. [MEDLINE: 93390905]
100. Velkova A. Treatment of pulpitis in deciduous molars [Prispevek k problematice leceni docasnych pulpitickych molaru]. Ceskoslovenska Stomatologie 1977;77(4):277-81. [PUBMED: 269022]
101. Yakushiji M, Sasamoto K, Imanishi T, Machida Y, Sekine N. Clinical study of vital pulpotomy with Calvital on deciduous teeth. Shikwa Gakuho 1969;69(2):271-5. [MEDLINE: 69190391]
102. al-Shalan TA, Erickson PR, Hardie NA. Primary incisor decay before age 4 as a risk factor for future dental caries. Pediatric Dentistry 1997;19(1):37-41. [PUBMED: 9048412]
103. Casas MJ, Kenny DJ, Judd PL, Johnston DH. Do we still need formocresol in pediatric dentistry?. Journal of the Canadian Dental Association) 2005;71(10):749-51. [PUBMED: 16324226]
104. US National Center for Health Statistics, Centers for Disease Control and Prevention. CDC Data & Statistics. Feature: Untreated Dental Caries (Cavities) in Children Ages 2-19, United States, 2011. Available from www.cdc.gov/Features/dsUntreatedCavitiesKids/ (accessed 5 June 2014).
105. Finucane D. Rationale for restoration of carious primary teeth: a review. European Archives of Paediatric Dentistry 2012;13(6):281-92. [PUBMED: 23235127]
106. Clinical Affairs Committee - Pulp Therapy Subcommittee. Guideline on Pulp Therapy for Primary and Immature Permanent Teeth. American Academy of Pediatric Dentistry 2009:212-9.
107. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org.
108. International Caries Detection and Assessment System Coordinating Committee. Rationale and Evidence for the International Caries Detection and Assessment System (ICDAS II), 2011. Available from www.icdas.org/downloads (accessed 5 June 2014).
109. Kaste LM, Marianos D, Chang R, Phipps KR. The assessment of nursing caries and its relationship to high caries in the permanent dentition. Journal of Public Health Dentistry 1992;52(2):64-8. [PUBMED: 1564693]
110. Lee YL, Chang HH. Comparison of Mineral Trioxide Aggregate (MTA) and 20% Formocresol (FC) in Pulpotomized Human Primary Molars. Available from www.clinicaltrials.gov/show/NCT00972556 (accessed 5 June 2014).
111. Milnes AR. Persuasive evidence that formocresol use in pediatric dentistry is safe. Journal of the Canadian Dental Association 2006;72(3):247-8. [PUBMED: 16696891]
112. National Health and Nutrition Examination Survey (NHANES). National Health and Nutrition Examination Survey Data (1999-2004). Available from www.cdc.gov/nchs/data/datalinkage/nh99+_mort_file_layout_public_2010.pdf (accessed 5 June 2014).
113. Selwitz RH, Ismail AI, Pitts NB. Dental caries. Lancet 2007;369(9555):51-9.
114. Smail-Faugeron V, Fron Chabouis H, Durieux P, Attal J P, Muller-Bolla M, Courson F. Development of a core set of outcomes for randomized controlled trials with multiple outcomes - example of pulp treatments of primary teeth for extensive decay in children. PLoS One 2013;8(1):e51908.
115. Whitehead A. Meta-Analysis of Controlled Clinical Trials. Chichester: Wiley, 2002:352.
116. Nadin G, Goel BR, Yeung CA, Glenny AM. Pulp treatment for extensive decay in primary teeth. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003220]